KOLELITIASIS1

Embed Size (px)

Citation preview

  • 8/13/2019 KOLELITIASIS1

    1/37

    KOLELITIASIS

    Dr. SUHAEMI, SpPD, FINASIM

  • 8/13/2019 KOLELITIASIS1

    2/37

    G LLBL DDER DISORDERS

    A. Cholelithiasis and Cholecystitis1. Definitions

    a. Cholelithiasis: formation of stones (calculi) withinthe gallbladder or biliary duct system

    b. Cholecystitis: inflammation of gall bladderc. Cholangitis: inflammation of the biliary ducts

    2. Pathophysiologya.Gallstones form due to

    1.Abnormal bile composition2.Biliary stasis3.Inflammation of gallbladder

  • 8/13/2019 KOLELITIASIS1

    3/37

    INTRODUCTION

  • 8/13/2019 KOLELITIASIS1

    4/37

    PATHOGENESISNormally, bile is sterile due to constant flush,bacteriostatic bile salts, secretory IgA, and biliary

    mucous; Sphincter of Oddi forms effective barrier toduodenal reflux and ascending infection

    ERCP or biliary stent insertion can disrupt the Sphincterof Oddi barrier mechanism , causing pathogeneic bacteriato enter the sterile biliary system.

    Obstruction from stone or tumor increases intrabiliarypressure

    High pressure diminishes host antibacterial defense- IgAproduction, bile flow- causing immune dysfunction,increasing small bowel bacterial colonization.

    Bacteria gain access to biliary tree by retrograde ascent

    Biliary obstruction (stone or stricture) causes bactibiliaE Coli (25-50%)Klebsiella (15-20%),Enterobacter (5-10%)

    High pressure pushes infection into biliary canaliculi,hepatic vein, and perihepatic lymphatics, favoringmigration into systemic circulation- bacteremia (20-40%).

    Adam.about.com

    Gpnotebook.co.uk Pathology.med.edu

  • 8/13/2019 KOLELITIASIS1

    5/37

    CLINICAL MANIFESTATIONS

    RUQ pain (65%)Fever (90%)

    May be absent in elderly patients

    Jaundice (60%)Hypotension (30%)

    Altered mental status (10%)

    CharcotsTriad:Found in50-70%of

    patients

    ReynoldsPentad:

    Additional History

    Pruitus, acholic stoolsPMH for gallstones, CBD stones,Recent ERCP, cholangiogram

    Additional PhysicalTachycardiaMild hepatomegaly

  • 8/13/2019 KOLELITIASIS1

    6/37

    ANATOMI

  • 8/13/2019 KOLELITIASIS1

    7/37

    ANATOMI

  • 8/13/2019 KOLELITIASIS1

    8/37

    ANATOMI

  • 8/13/2019 KOLELITIASIS1

    9/37

    COMMON LOCATIONS OF GALLSTONES

  • 8/13/2019 KOLELITIASIS1

    10/37

    G LL STONES

  • 8/13/2019 KOLELITIASIS1

    11/37

    NORMAL GALLBLADDER

  • 8/13/2019 KOLELITIASIS1

    12/37

    Abdominal x-ray film,

    showing a porcelaingallbladder. This is theterm used to describe agallbladder with acalcified wall.

  • 8/13/2019 KOLELITIASIS1

    13/37

    ABDOMINAL X-RAY DEMONSTRATING STONES IN THEGALLBLADDER

  • 8/13/2019 KOLELITIASIS1

    14/37

    GALLBLADDER, WITH NUMEROUS STONES PRESENT

  • 8/13/2019 KOLELITIASIS1

    15/37

    GALLBLADDER, WITH SLUDGE PRESENT (ARROW)

  • 8/13/2019 KOLELITIASIS1

    16/37

    ACUTE CHOLECYSTITIS NOTICE INCREASED GALLBLADDER WALLTHICKNESS

  • 8/13/2019 KOLELITIASIS1

    17/37

  • 8/13/2019 KOLELITIASIS1

    18/37

    DIAGNOSIS: FIRST-LINE IMAGINGUltrasonography

    Advan tage :Sensitive for intrahepatic/extrahepatic/CBD dilatation

    CBD diameter > 6 mm on US associated with high prevalence ofcholedocholithaisisOf cholangitis patients, dilated CBD found in 64%,

    Rapid at bedsideCan image aorta, pancreas, liverIdentify complications: perforation, empyema, abscess

    DisadvantageNot useful for choledocholithiasis:

    Of cholangitis patients, CBD stones observed in 13% 10-20% falsely negative - normal U/S does not r/o cholangitis

    acute obstruction when there is no time to dilateSmall stones in bile duct in 10-20% of cases

    CTAdvan tages

    CT cholangiograhy enhances CBD stones and increases detection of biliarypathology

    Sensitivity for CBD stones is 95%Can image other pathologies: ampullary tumors, pericholecystic fluid, liver abscessCan visualize other pathologies- cholangitis: diverticuliits, pyelonephritis,mesenteric ischemia, ruptured appendix

    DisadvantagesSensitivity to contrastPoor imaging of gallstones

    Med.virgina.edu

    Soto et al. J. Roenterology. 2000

  • 8/13/2019 KOLELITIASIS1

    19/37

    PERCUTANEOUS TRANSHEPATICCHOLANGIOGRAM (PTC)

    PTC is indicated when percutaneousintervention is needed and ERCP either isinappropriate or has failed.Can be used to drain biliary obstructions.

  • 8/13/2019 KOLELITIASIS1

    20/37

    PTC

  • 8/13/2019 KOLELITIASIS1

    21/37

    PTC after injection ofdye, showing a largegallstone trapped inthe duct.

  • 8/13/2019 KOLELITIASIS1

    22/37

    PTC: The same ductas before, afterremoval of the stonethrough the drainagecatheter.

  • 8/13/2019 KOLELITIASIS1

    23/37

    ENDOSCOPIC RETROGRADECHOLANGIOPANCREATOGRAPHY (ERCP)

    ERCP is the primary method of directcholangiography, and has therapeuticpotential. It also allows for examination of the

    upper GI tract, the papilla of Vater, and thepancreatic duct. Biopsies of multiple sitescan be taken using this technique.ERCP causes less discomfort than PTC, butacute pancreatitis is a common complication(which is rarely seen in PTC).

  • 8/13/2019 KOLELITIASIS1

    24/37

    ERCP: THE ENDOSCOPE IS INTRODUCED AND IS THREADED AROUND TO THE

    SPHINCTER OF ODDI. THERE, DYE CAN BE INJECTED INTO THE DUCTS.INSTRUMENTS CAN ALSO BE INSERTED THROUGH THE SCOPE TO REMOVESTONES, INSERT DRAINS, REMOVE TISSUE SAMPLES, OF PERFORM OTHERTREATMENTS.

  • 8/13/2019 KOLELITIASIS1

    25/37

  • 8/13/2019 KOLELITIASIS1

    26/37

    ERCP

  • 8/13/2019 KOLELITIASIS1

    27/37

    ERCP(THERAPUTIC)

  • 8/13/2019 KOLELITIASIS1

    28/37

    MAGNETIC RESONANCECHOLANGIOPANCREATOGRAPHY (MRCP)

    MRCP is becoming a more viable imagingtechnique, as MRI technology improves. However,CT and ultrasound are faster, easier, and morereadily available, so they are used more frequentlythan MRCP.MRCP is emerging as a new tool for non-invasiveevaluation of the pancreatic and biliary ductalsystems.MRCP is gradually replacing PTC and ERCP fordiagnostic purposes.

  • 8/13/2019 KOLELITIASIS1

    29/37

    MRCP

  • 8/13/2019 KOLELITIASIS1

    30/37

    MRCP WITH STONES IN THE DUCT

  • 8/13/2019 KOLELITIASIS1

    31/37

  • 8/13/2019 KOLELITIASIS1

    32/37

    MANAGEMENT

    1-Nonsurgical treatment2-Surgical treatment

    PreoperativeIntraoperativepostoperative

  • 8/13/2019 KOLELITIASIS1

    33/37

    1-NONSURGICAL TREATMENT

    Oral dissolution therapy

    Aim: dissolute small radiolucent stoneDX:chenodeoxycholic acid& ursodeoxycholic

    acidSide effect: diarrhea, pruritus, transient raise in

    serum transaminasesDisadvantage: long term treatment (mnths)

    high recurrence rate

  • 8/13/2019 KOLELITIASIS1

    34/37

    1-NONSURGICAL TREATMENT

    Extracorporal shock wave lithiotrepsy Aim: medium sized radiolucent stone DX:+\- ODTSide effect biliary colic as fragments pass

    through cystic duct

  • 8/13/2019 KOLELITIASIS1

    35/37

    PEMBEDAHAN

    Operation ;1-gallstone inCBD:ERCP2-trumatic stricture:bypass via Roux loop of

    intestinal anastomosed to the proximal dil3-cholangiocarcinoma:stenting +radiotherapy

    4-CA of head of the pancreas or AOV:whipples operation:

  • 8/13/2019 KOLELITIASIS1

    36/37

    WHIPPLE PROCEDURE

  • 8/13/2019 KOLELITIASIS1

    37/37

    POSTOPERATIVE MANAGEMENT

    Complication

    Coagulation disorderRenal failureGIT hemorrhage (stress ulcer)Delayed wound healing